More than 430,000 bottles of painkillers under the Excedrin brand have been recalled due to a manufacturing defect that may have left holes in the bottom of Excedrin bottles.
GlaxoSmithKline (GSK), Excedrin’s manufacturer, announced the recall Wednesday for many of its aspirin and acetaminophen-based, over-the-counter products sold nationwide between March 2018 and September 2020.
The products sold under the names Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets violated the Poison Prevention Packaging Act, which mandates childproof packaging for over-the-counter and prescription drugs, among other possibly hazardous household products.
A full list of products can be found on the GSK website.
If You Have This OTC Medicine, You Need to Check Your Bottle Immediately
By Kali Coleman of Best Life |
If You Have This OTC Medicine, You Need to Check Your Bottle Immediately
Storing medications in your home can be a tricky task, since you need to keep them away from children and pets. But one popular over-the-counter medicine may pose an even bigger safety risk, especially if you keep it in the wrong place. If you have Excedrin in your home, you need to check your bottle immediately. Keep reading to find out why this medicine was recalled, and for more essential safety warnings, If You Have This Popular Frozen Meal at Home, Throw It Away Right Now.
More than 433K Excedrin bottles recalled due to bottles having holes on bottom
GSK
Excedrin s manufacturer has recalled more than 433,000 bottles of the painkillers due to bottles having holes on the bottom of them.
and last updated 2020-12-23 15:47:27-05
Excedrin s manufacturer has recalled more than 433,000 bottles of the painkillers due to bottles having holes on the bottom of them.
GlaxoSmithKline (GSK) issued the recall Wednesday stating that the bottles aren t in child-resistant packaging as required by the Poison Prevention Packaging Act since there are holes in the bottom.
GSK says this could potentially lead to children gaining access and swallowing the over-the-counter drug, posing a risk of poisoning.